Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

298 Press Releases
DateTitleCompany
10 Dec 14 Teva Announces Launch of First Generic Celebrex® Capsules in the United States Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
01 Dec 14 Teva to Host 2015 Business Outlook Conference Call and Webcast on December 11 2014 Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
01 Dec 14 Teva Announces Launch of Generic Exforge HCT® Tablets in the United States Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
06 Oct 14 Teva to Report Third Quarter 2014 Financial Results on October 30 2014 Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
04 Sep 14 Teva Announces Launch of Generic Baraclude® Tablets 0.5mg and 1mg in the United States Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
03 Sep 14 Teva Announces UK High Court Gives Positive Judgment in the Company’s Patent Case Against AstraZeneca Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
07 Aug 14 Teva Comments on Receipt of First Paragraph IV Notice for COPAXONE® 40 mg/mL (glatiramer acetate injection) Formulation Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
30 Jul 14 All Proposals Approved at Teva's Annual Meeting of Shareholders Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
18 Jul 14 Teva to Report Second Quarter 2014 Financial Results on July 31, 2014 Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
16 Jul 14 Leading U.S. Proxy Advisory Firm Supports Teva Nominees and Other Shareholders’ Meeting Proposals Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
20 Jun 14 Teva Reaches Settlement in ProAir® HFA Patent Case Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
17 Jun 14 Teva Reaches Settlements In NUVIGIL® Patent Case Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
12 Jun 14 Teva Announces U.S. Court of Appeals Upholds Ruling Confirming Invalidity of Baraclude® Patent Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
05 Jun 14 Teva to Present at the Goldman Sachs 35th Annual Global Healthcare Conference Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
30 May 14 Teva Receives Favorable Court Decision Regarding Generic Celebrex® Capsules; Teva Should Receive Sole Exclusivity for Generic Celebrex® Capsules Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
29 May 14 Teva to Present at the Jefferies 2014 Global Healthcare Conference Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
27 May 14 Teva Announces Favorable European Patent Office Ruling in COPAXONE® Patent Proceeding Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
15 May 14 Teva to Present at the UBS Global Healthcare Conference Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
09 May 14 Teva to Present at the Bank of America Merrill Lynch 2014 Health Care Conference Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
30 Apr 14 Teva Issues Updated Conference Call Information for First Quarter 2014 Financial Results on May 1, 2014 Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
19 Apr 14 Teva Announces Supreme Court Denial of Request for Interim Relief to Stay Court of Appeals Ruling for COPAXONE® Patent Due to the Potential for the Company to Recover Patent Infringement Damages Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
17 Apr 14 Teva Settles Patent Litigation with Pfizer on Celebrex® Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
15 Apr 14 Teva Announces Launch of Generic Lunesta® Tablets in the United States Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
08 Apr 14 Teva Announces First Approval and Launch of Generic Lovaza® Capsules in the United States Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
31 Mar 14 Teva Announces U.S. Supreme Court Will Hear Its Appeal on COPAXONE® Patent Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
20 Mar 14 Teva to Report First Quarter 2014 Financial Results on May 1, 2014 Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
07 Mar 14 Teva Announces Launch of Generic Xeloda® Tablets 150 MG and 500 MG in the United States Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
04 Mar 14 Teva Announces Approval of Generic Evista® Tablets 60 mg in the United States Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
28 Feb 14 Teva to Present at the Cowen & Company 34th Annual Healthcare Conference Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
24 Feb 14 Teva to Present at the Citi 2014 Global Healthcare Conference Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.